TI
VIR icon

Tidal Investments’s Vir Biotechnology VIR Stock Holding History

Tidal Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,755
Closed -$265K – 1982
2024
Q2 		$265K Sell
29,755
-4,995
-14% -$47.9K ﹤0.01% 1587
2024
Q1 		$352K Buy
+34,750
New +$354K 0.01% 1341
2023
Q2 		– Sell
-20,015
Closed -$466K – 1401
2023
Q1 		$466K Buy
+20,015
New +$512K 0.02% 794

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Tidal Investments's VIR Position: Q3 2024 in Review

Tidal Investments sold out of Vir Biotechnology (VIR) in Q3 2024, closing a stake of 29,755 shares — an estimated $265K sold.

Tidal Investments first reported a position in VIR in Q1 2023 and held it in 3 quarters. The position peaked at $466K in Q1 2023. 197 funds tracked by Wall St. Rank hold VIR as of Q3 2024.

  • Tidal Investments reported no remaining Vir Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Tidal Investments sold 29,755 Vir Biotechnology shares in Q3 2024, an estimated $265K.
  • Tidal Investments first reported a position in Vir Biotechnology in Q1 2023 and held it in 3 quarters.
  • Tidal Investments's Vir Biotechnology position peaked at $466K in Q1 2023.
  • 197 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2024.

Based on Tidal Investments's 13F filing for Q3 2024, filed 14 Nov 2024.